<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2008-02-05" modified="2020-08-12" version="120">
<accession>Q3U182</accession>
<accession>Q3TA52</accession>
<accession>Q8BH09</accession>
<name>CRTC2_MOUSE</name>
<protein>
<recommendedName>
<fullName>CREB-regulated transcription coactivator 2</fullName>
</recommendedName>
<alternativeName>
<fullName>Transducer of regulated cAMP response element-binding protein 2</fullName>
<shortName>TORC-2</shortName>
<shortName>Transducer of CREB protein 2</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">Crtc2</name>
<name type="synonym">Torc2</name>
</gene>
<organism>
<name type="scientific">Mus musculus</name>
<name type="common">Mouse</name>
<dbReference type="NCBI Taxonomy" id="10090"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Glires</taxon>
<taxon>Rodentia</taxon>
<taxon>Myomorpha</taxon>
<taxon>Muroidea</taxon>
<taxon>Muridae</taxon>
<taxon>Murinae</taxon>
<taxon>Mus</taxon>
<taxon>Mus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2005" name="Science" volume="309" first="1559" last="1563">
<title>The transcriptional landscape of the mammalian genome.</title>
<authorList>
<person name="Carninci P."/>
<person name="Kasukawa T."/>
<person name="Katayama S."/>
<person name="Gough J."/>
<person name="Frith M.C."/>
<person name="Maeda N."/>
<person name="Oyama R."/>
<person name="Ravasi T."/>
<person name="Lenhard B."/>
<person name="Wells C."/>
<person name="Kodzius R."/>
<person name="Shimokawa K."/>
<person name="Bajic V.B."/>
<person name="Brenner S.E."/>
<person name="Batalov S."/>
<person name="Forrest A.R."/>
<person name="Zavolan M."/>
<person name="Davis M.J."/>
<person name="Wilming L.G."/>
<person name="Aidinis V."/>
<person name="Allen J.E."/>
<person name="Ambesi-Impiombato A."/>
<person name="Apweiler R."/>
<person name="Aturaliya R.N."/>
<person name="Bailey T.L."/>
<person name="Bansal M."/>
<person name="Baxter L."/>
<person name="Beisel K.W."/>
<person name="Bersano T."/>
<person name="Bono H."/>
<person name="Chalk A.M."/>
<person name="Chiu K.P."/>
<person name="Choudhary V."/>
<person name="Christoffels A."/>
<person name="Clutterbuck D.R."/>
<person name="Crowe M.L."/>
<person name="Dalla E."/>
<person name="Dalrymple B.P."/>
<person name="de Bono B."/>
<person name="Della Gatta G."/>
<person name="di Bernardo D."/>
<person name="Down T."/>
<person name="Engstrom P."/>
<person name="Fagiolini M."/>
<person name="Faulkner G."/>
<person name="Fletcher C.F."/>
<person name="Fukushima T."/>
<person name="Furuno M."/>
<person name="Futaki S."/>
<person name="Gariboldi M."/>
<person name="Georgii-Hemming P."/>
<person name="Gingeras T.R."/>
<person name="Gojobori T."/>
<person name="Green R.E."/>
<person name="Gustincich S."/>
<person name="Harbers M."/>
<person name="Hayashi Y."/>
<person name="Hensch T.K."/>
<person name="Hirokawa N."/>
<person name="Hill D."/>
<person name="Huminiecki L."/>
<person name="Iacono M."/>
<person name="Ikeo K."/>
<person name="Iwama A."/>
<person name="Ishikawa T."/>
<person name="Jakt M."/>
<person name="Kanapin A."/>
<person name="Katoh M."/>
<person name="Kawasawa Y."/>
<person name="Kelso J."/>
<person name="Kitamura H."/>
<person name="Kitano H."/>
<person name="Kollias G."/>
<person name="Krishnan S.P."/>
<person name="Kruger A."/>
<person name="Kummerfeld S.K."/>
<person name="Kurochkin I.V."/>
<person name="Lareau L.F."/>
<person name="Lazarevic D."/>
<person name="Lipovich L."/>
<person name="Liu J."/>
<person name="Liuni S."/>
<person name="McWilliam S."/>
<person name="Madan Babu M."/>
<person name="Madera M."/>
<person name="Marchionni L."/>
<person name="Matsuda H."/>
<person name="Matsuzawa S."/>
<person name="Miki H."/>
<person name="Mignone F."/>
<person name="Miyake S."/>
<person name="Morris K."/>
<person name="Mottagui-Tabar S."/>
<person name="Mulder N."/>
<person name="Nakano N."/>
<person name="Nakauchi H."/>
<person name="Ng P."/>
<person name="Nilsson R."/>
<person name="Nishiguchi S."/>
<person name="Nishikawa S."/>
<person name="Nori F."/>
<person name="Ohara O."/>
<person name="Okazaki Y."/>
<person name="Orlando V."/>
<person name="Pang K.C."/>
<person name="Pavan W.J."/>
<person name="Pavesi G."/>
<person name="Pesole G."/>
<person name="Petrovsky N."/>
<person name="Piazza S."/>
<person name="Reed J."/>
<person name="Reid J.F."/>
<person name="Ring B.Z."/>
<person name="Ringwald M."/>
<person name="Rost B."/>
<person name="Ruan Y."/>
<person name="Salzberg S.L."/>
<person name="Sandelin A."/>
<person name="Schneider C."/>
<person name="Schoenbach C."/>
<person name="Sekiguchi K."/>
<person name="Semple C.A."/>
<person name="Seno S."/>
<person name="Sessa L."/>
<person name="Sheng Y."/>
<person name="Shibata Y."/>
<person name="Shimada H."/>
<person name="Shimada K."/>
<person name="Silva D."/>
<person name="Sinclair B."/>
<person name="Sperling S."/>
<person name="Stupka E."/>
<person name="Sugiura K."/>
<person name="Sultana R."/>
<person name="Takenaka Y."/>
<person name="Taki K."/>
<person name="Tammoja K."/>
<person name="Tan S.L."/>
<person name="Tang S."/>
<person name="Taylor M.S."/>
<person name="Tegner J."/>
<person name="Teichmann S.A."/>
<person name="Ueda H.R."/>
<person name="van Nimwegen E."/>
<person name="Verardo R."/>
<person name="Wei C.L."/>
<person name="Yagi K."/>
<person name="Yamanishi H."/>
<person name="Zabarovsky E."/>
<person name="Zhu S."/>
<person name="Zimmer A."/>
<person name="Hide W."/>
<person name="Bult C."/>
<person name="Grimmond S.M."/>
<person name="Teasdale R.D."/>
<person name="Liu E.T."/>
<person name="Brusic V."/>
<person name="Quackenbush J."/>
<person name="Wahlestedt C."/>
<person name="Mattick J.S."/>
<person name="Hume D.A."/>
<person name="Kai C."/>
<person name="Sasaki D."/>
<person name="Tomaru Y."/>
<person name="Fukuda S."/>
<person name="Kanamori-Katayama M."/>
<person name="Suzuki M."/>
<person name="Aoki J."/>
<person name="Arakawa T."/>
<person name="Iida J."/>
<person name="Imamura K."/>
<person name="Itoh M."/>
<person name="Kato T."/>
<person name="Kawaji H."/>
<person name="Kawagashira N."/>
<person name="Kawashima T."/>
<person name="Kojima M."/>
<person name="Kondo S."/>
<person name="Konno H."/>
<person name="Nakano K."/>
<person name="Ninomiya N."/>
<person name="Nishio T."/>
<person name="Okada M."/>
<person name="Plessy C."/>
<person name="Shibata K."/>
<person name="Shiraki T."/>
<person name="Suzuki S."/>
<person name="Tagami M."/>
<person name="Waki K."/>
<person name="Watahiki A."/>
<person name="Okamura-Oho Y."/>
<person name="Suzuki H."/>
<person name="Kawai J."/>
<person name="Hayashizaki Y."/>
</authorList>
<dbReference type="PubMed" id="16141072"/>
<dbReference type="DOI" id="10.1126/science.1112014"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<strain>NOD</strain>
<tissue>Spleen</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<strain>FVB/N</strain>
<tissue>Liver</tissue>
<tissue>Mammary tumor</tissue>
<tissue>Salivary gland</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2005" name="Nature" volume="437" first="1109" last="1111">
<title>The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism.</title>
<authorList>
<person name="Koo S.-H."/>
<person name="Flechner L."/>
<person name="Qi L."/>
<person name="Zhang X."/>
<person name="Screaton R.A."/>
<person name="Jeffries S."/>
<person name="Hedrick S."/>
<person name="Xu W."/>
<person name="Boussouar F."/>
<person name="Brindle P."/>
<person name="Takemori H."/>
<person name="Montminy M."/>
</authorList>
<dbReference type="PubMed" id="16148943"/>
<dbReference type="DOI" id="10.1038/nature03967"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT SER-171</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2005" name="Science" volume="310" first="1642" last="1646">
<title>The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.</title>
<authorList>
<person name="Shaw R.J."/>
<person name="Lamia K.A."/>
<person name="Vasquez D."/>
<person name="Koo S.-H."/>
<person name="Bardeesy N."/>
<person name="Depinho R.A."/>
<person name="Montminy M."/>
<person name="Cantley L.C."/>
</authorList>
<dbReference type="PubMed" id="16308421"/>
<dbReference type="DOI" id="10.1126/science.1120781"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT SER-171</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2007" name="Nature" volume="449" first="366" last="369">
<title>Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2.</title>
<authorList>
<person name="Dentin R."/>
<person name="Liu Y."/>
<person name="Koo S.-H."/>
<person name="Hedrick S."/>
<person name="Vargas T."/>
<person name="Heredia J."/>
<person name="Yates J. III"/>
<person name="Montminy M."/>
</authorList>
<dbReference type="PubMed" id="17805301"/>
<dbReference type="DOI" id="10.1038/nature06128"/>
</citation>
<scope>INTERACTION WITH COP1</scope>
<scope>PHOSPHORYLATION AT SER-171</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF SER-171; VAL-214; PRO-215 AND LYS-628</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="1488" last="1493">
<title>Large-scale phosphorylation analysis of mouse liver.</title>
<authorList>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Gerber S.A."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="17242355"/>
<dbReference type="DOI" id="10.1073/pnas.0609836104"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-612</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2009" name="Immunity" volume="30" first="143" last="154">
<title>The phagosomal proteome in interferon-gamma-activated macrophages.</title>
<authorList>
<person name="Trost M."/>
<person name="English L."/>
<person name="Lemieux S."/>
<person name="Courcelles M."/>
<person name="Desjardins M."/>
<person name="Thibault P."/>
</authorList>
<dbReference type="PubMed" id="19144319"/>
<dbReference type="DOI" id="10.1016/j.immuni.2008.11.006"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2010" name="Cell" volume="143" first="1174" last="1189">
<title>A tissue-specific atlas of mouse protein phosphorylation and expression.</title>
<authorList>
<person name="Huttlin E.L."/>
<person name="Jedrychowski M.P."/>
<person name="Elias J.E."/>
<person name="Goswami T."/>
<person name="Rad R."/>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Haas W."/>
<person name="Sowa M.E."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="21183079"/>
<dbReference type="DOI" id="10.1016/j.cell.2010.12.001"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70; SER-171; SER-434; SER-612; SER-622 AND SER-623</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Brain</tissue>
<tissue>Brown adipose tissue</tissue>
<tissue>Heart</tissue>
<tissue>Kidney</tissue>
<tissue>Liver</tissue>
<tissue>Lung</tissue>
<tissue>Pancreas</tissue>
<tissue>Spleen</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2013" name="J. Neurosci." volume="33" first="9021" last="9027">
<title>Clock and light regulation of the CREB coactivator CRTC1 in the suprachiasmatic circadian clock.</title>
<authorList>
<person name="Sakamoto K."/>
<person name="Norona F.E."/>
<person name="Alzate-Correa D."/>
<person name="Scarberry D."/>
<person name="Hoyt K.R."/>
<person name="Obrietan K."/>
</authorList>
<dbReference type="PubMed" id="23699513"/>
<dbReference type="DOI" id="10.1523/jneurosci.4202-12.2013"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
<title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
<authorList>
<person name="Guo A."/>
<person name="Gu H."/>
<person name="Zhou J."/>
<person name="Mulhern D."/>
<person name="Wang Y."/>
<person name="Lee K.A."/>
<person name="Yang V."/>
<person name="Aguiar M."/>
<person name="Kornhauser J."/>
<person name="Jia X."/>
<person name="Ren J."/>
<person name="Beausoleil S.A."/>
<person name="Silva J.C."/>
<person name="Vemulapalli V."/>
<person name="Bedford M.T."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="24129315"/>
<dbReference type="DOI" id="10.1074/mcp.o113.027870"/>
</citation>
<scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-161</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryo</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2014" name="Sci. Signal." volume="7" first="RA19" last="RA19">
<title>Arginine methylation of CRTC2 is critical in the transcriptional control of hepatic glucose metabolism.</title>
<authorList>
<person name="Han H.S."/>
<person name="Jung C.Y."/>
<person name="Yoon Y.S."/>
<person name="Choi S."/>
<person name="Choi D."/>
<person name="Kang G."/>
<person name="Park K.G."/>
<person name="Kim S.T."/>
<person name="Koo S.H."/>
</authorList>
<dbReference type="PubMed" id="24570487"/>
<dbReference type="DOI" id="10.1126/scisignal.2004479"/>
</citation>
<scope>METHYLATION AT ARG-51; ARG-99; ARG-120; ARG-123; ARG-161 AND ARG-168</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2018" name="FEBS J." volume="285" first="467" last="480">
<title>14-3-3 proteins mediate inhibitory effects of cAMP on salt-inducible kinases (SIKs).</title>
<authorList>
<person name="Sonntag T."/>
<person name="Vaughan J.M."/>
<person name="Montminy M."/>
</authorList>
<dbReference type="PubMed" id="29211348"/>
<dbReference type="DOI" id="10.1111/febs.14351"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT SER-171</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2017" name="PLoS ONE" volume="12" first="E0173013" last="E0173013">
<title>Analysis of a cAMP regulated coactivator family reveals an alternative phosphorylation motif for AMPK family members.</title>
<authorList>
<person name="Sonntag T."/>
<person name="Moresco J.J."/>
<person name="Vaughan J.M."/>
<person name="Matsumura S."/>
<person name="Yates J.R. III"/>
<person name="Montminy M."/>
</authorList>
<dbReference type="PubMed" id="28235073"/>
<dbReference type="DOI" id="10.1371/journal.pone.0173013"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>PHOSPHORYLATION AT SER-70; THR-169 AND SER-171</scope>
<scope>MUTAGENESIS OF SER-171 AND SER-275</scope>
<scope>INTERACTION WITH 14-3-3 PROTEINS</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2018" name="IScience" volume="11" first="134" last="145">
<title>Mitogenic Signals Stimulate the CREB Coactivator CRTC3 through PP2A Recruitment.</title>
<authorList>
<person name="Sonntag T."/>
<person name="Ostojic J."/>
<person name="Vaughan J.M."/>
<person name="Moresco J.J."/>
<person name="Yoon Y.S."/>
<person name="Yates J.R. III"/>
<person name="Montminy M."/>
</authorList>
<dbReference type="PubMed" id="30611118"/>
<dbReference type="DOI" id="10.1016/j.isci.2018.12.012"/>
</citation>
<scope>INTERACTION WITH YWHAE AND PPP3CA</scope>
<scope>PHOSPHORYLATION AT SER-171 AND SER-275</scope>
</reference>
<comment type="function">
<text evidence="6 7 8 13">Transcriptional coactivator for CREB1 which activates transcription through both consensus and variant cAMP response element (CRE) sites (PubMed:29211348). Acts as a coactivator, in the SIK/TORC signaling pathway, being active when dephosphorylated (PubMed:29211348). Acts independently of CREB1 'Ser-133' phosphorylation. Enhances the interaction of CREB1 with TAF4. Regulates gluconeogenesis as a component of the LKB1/AMPK/TORC2 signaling pathway. Regulates the expression of specific genes such as the steroidogenic gene, StAR. Potent coactivator of PPARGC1A and inducer of mitochondrial biogenesis in muscle cells (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="6 9 12 14">Binds, as a tetramer, through its N-terminal region, with the bZIP domain of CREB1. 'Arg-314' in the bZIP domain of CREB1 is essential for this interaction. Interaction, via its C-terminal, with TAF4, enhances recruitment of TAF4 to CREB1. Interacts with SIK2 (By similarity). Interacts with 14-3-3 proteins, YWHAB and YWHAG (PubMed:28235073). Interacts (probably when phosphorylated at Ser-171) with YWHAE (PubMed:30611118). Interacts with calmodulin-dependent catalytic subunit PPP3CA/calcineurin A (PubMed:30611118). Interaction with COP1 mediates nuclear export and degradation of CRTC2 (PubMed:17805301).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-8018890">
<id>Q3U182</id>
</interactant>
<interactant intactId="EBI-6171558">
<id>F6VAN0</id>
<label>Atf6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-8018890">
<id>Q3U182</id>
</interactant>
<interactant intactId="EBI-15656898">
<id>Q9R1A8</id>
<label>Cop1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-8018890">
<id>Q3U182</id>
</interactant>
<interactant intactId="EBI-397208">
<id>P63328</id>
<label>Ppp3ca</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-8018890">
<id>Q3U182</id>
</interactant>
<interactant intactId="EBI-852157">
<id>P18850</id>
<label>ATF6</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-8018890">
<id>Q3U182</id>
</interactant>
<interactant intactId="EBI-15683709">
<id>P29994-1</id>
<label>Itpr1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="7 8 9 13">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="7 8 9 13">Nucleus</location>
</subcellularLocation>
<text evidence="6 7">Translocated from the nucleus to the cytoplasm on interaction of the phosphorylated form with 14-3-3 protein (By similarity). In response to cAMP levels and glucagon, relocated to the nucleus (PubMed:16148943).</text>
</comment>
<comment type="tissue specificity">
<text evidence="10">Expressed in the suprachiasmatic nucleus (SCN) of the brain.</text>
</comment>
<comment type="PTM">
<text evidence="6 13 14">Phosphorylation/dephosphorylation states of Ser-171 are required for regulating transduction of CREB activity (PubMed:29211348). CRTCs/TORCs are inactive when phosphorylated, and active when dephosphorylated at this site (PubMed:29211348). This primary site of phosphorylation, is regulated by cAMP and calcium levels and is dependent on the phosphorylation of SIKs (SIK1 and SIK2) by LKB1 (By similarity). Following adenylyl cyclase activation, dephosphorylated at Ser-171 by PPP3CA/calcineurin A resulting in CRTC2 dissociation from 14-3-3 proteins and PPP3CA (PubMed:30611118). Phosphorylation at Ser-275 by MARK2 is induced under low glucose conditions and dephosphorylated in response to glucose influx (By similarity). Both insulin and AMPK increase this phosphorylation of CRTC2 while glucagon suppresses it (By similarity). Phosphorylation at Ser-275 promotes interaction with 14-3-3 proteins and translocation to the cytoplasm (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="11">Asymmetric dimethylation of arginine resisues by PRMT6 enhances the association of CRTC2 with CREB on the promoters of gluconeogenic genes.</text>
</comment>
<comment type="similarity">
<text evidence="15">Belongs to the TORC family.</text>
</comment>
<dbReference type="EMBL" id="AK156192">
<property type="protein sequence ID" value="BAE33618.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK172084">
<property type="protein sequence ID" value="BAE42818.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC023831">
<property type="protein sequence ID" value="AAH23831.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC032183">
<property type="protein sequence ID" value="AAH32183.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC033300">
<property type="protein sequence ID" value="AAH33300.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS38501.1"/>
<dbReference type="RefSeq" id="NP_083157.1">
<property type="nucleotide sequence ID" value="NM_028881.2"/>
</dbReference>
<dbReference type="PDB" id="5ZK1">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.05"/>
<property type="chains" value="C=17-58"/>
</dbReference>
<dbReference type="PDB" id="5ZKO">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.05"/>
<property type="chains" value="G/H=1-80"/>
</dbReference>
<dbReference type="PDBsum" id="5ZK1"/>
<dbReference type="PDBsum" id="5ZKO"/>
<dbReference type="SMR" id="Q3U182"/>
<dbReference type="BioGRID" id="216678">
<property type="interactions" value="9"/>
</dbReference>
<dbReference type="DIP" id="DIP-46162N"/>
<dbReference type="ELM" id="Q3U182"/>
<dbReference type="IntAct" id="Q3U182">
<property type="interactions" value="11"/>
</dbReference>
<dbReference type="STRING" id="10090.ENSMUSP00000029545"/>
<dbReference type="iPTMnet" id="Q3U182"/>
<dbReference type="PhosphoSitePlus" id="Q3U182"/>
<dbReference type="EPD" id="Q3U182"/>
<dbReference type="jPOST" id="Q3U182"/>
<dbReference type="MaxQB" id="Q3U182"/>
<dbReference type="PaxDb" id="Q3U182"/>
<dbReference type="PeptideAtlas" id="Q3U182"/>
<dbReference type="PRIDE" id="Q3U182"/>
<dbReference type="Antibodypedia" id="34141">
<property type="antibodies" value="534 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENSMUST00000029545">
<property type="protein sequence ID" value="ENSMUSP00000029545"/>
<property type="gene ID" value="ENSMUSG00000027936"/>
</dbReference>
<dbReference type="GeneID" id="74343"/>
<dbReference type="KEGG" id="mmu:74343"/>
<dbReference type="UCSC" id="uc008qbt.2">
<property type="organism name" value="mouse"/>
</dbReference>
<dbReference type="CTD" id="200186"/>
<dbReference type="MGI" id="MGI:1921593">
<property type="gene designation" value="Crtc2"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG502QVWA">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000010652"/>
<dbReference type="InParanoid" id="Q3U182"/>
<dbReference type="KO" id="K16333"/>
<dbReference type="OMA" id="RHIIDSS"/>
<dbReference type="OrthoDB" id="1118500at2759"/>
<dbReference type="PhylomeDB" id="Q3U182"/>
<dbReference type="TreeFam" id="TF321571"/>
<dbReference type="BioGRID-ORCS" id="74343">
<property type="hits" value="1 hit in 18 CRISPR screens"/>
</dbReference>
<dbReference type="PRO" id="PR:Q3U182"/>
<dbReference type="Proteomes" id="UP000000589">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="RNAct" id="Q3U182">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSMUSG00000027936">
<property type="expression patterns" value="Expressed in cardiac ventricle and 255 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="Q3U182">
<property type="organism ID" value="MM"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008140">
<property type="term" value="F:cAMP response element binding protein binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0006094">
<property type="term" value="P:gluconeogenesis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042593">
<property type="term" value="P:glucose homeostasis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043970">
<property type="term" value="P:histone H3-K9 acetylation"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0032793">
<property type="term" value="P:positive regulation of CREB transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0051289">
<property type="term" value="P:protein homotetramerization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:1901998">
<property type="term" value="P:toxin transport"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="InterPro" id="IPR024786">
<property type="entry name" value="TORC"/>
</dbReference>
<dbReference type="InterPro" id="IPR024785">
<property type="entry name" value="TORC_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR024784">
<property type="entry name" value="TORC_M"/>
</dbReference>
<dbReference type="InterPro" id="IPR024783">
<property type="entry name" value="TORC_N"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR13589">
<property type="entry name" value="PTHR13589"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF12886">
<property type="entry name" value="TORC_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF12885">
<property type="entry name" value="TORC_M"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF12884">
<property type="entry name" value="TORC_N"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="6">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="CREB-regulated transcription coactivator 2" id="PRO_0000318529">
<location>
<begin position="2"/>
<end position="692"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with COP1" evidence="9">
<location>
<begin position="209"/>
<end position="215"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear export signal" evidence="5">
<location>
<begin position="272"/>
<end position="288"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="237"/>
<end position="241"/>
</location>
</feature>
<feature type="compositionally biased region" description="Ser-rich">
<location>
<begin position="337"/>
<end position="413"/>
</location>
</feature>
<feature type="site" description="Required for ubiquitination and degradation">
<location>
<position position="628"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="6">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; by PRMT6" evidence="11">
<location>
<position position="51"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 12">
<location>
<position position="70"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="86"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="90"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; by PRMT6" evidence="11">
<location>
<position position="99"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; by PRMT6" evidence="11">
<location>
<position position="120"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; by PRMT6" evidence="11">
<location>
<position position="123"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="136"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; by PRMT6" evidence="4 11">
<location>
<position position="161"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; by PRMT6" evidence="11">
<location>
<position position="168"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="12">
<location>
<position position="169"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by AMPK, MARK2, SIK1 and SIK2" evidence="3 7 8 9 12 13 14">
<location>
<position position="171"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="6">
<location>
<position position="192"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="275"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="307"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="369"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="394"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="434"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="457"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="6">
<location>
<position position="489"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="490"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="493"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="6">
<location>
<position position="502"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 3">
<location>
<position position="612"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="622"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="623"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="6">
<location>
<position position="235"/>
</location>
</feature>
<feature type="mutagenesis site" description="Upregulates CREB transcription factor activity. Reduces interaction with 14-3-3 proteins." evidence="12">
<original>S</original>
<variation>A</variation>
<location>
<position position="171"/>
</location>
</feature>
<feature type="mutagenesis site" description="Upregulates CREB-mediated gluconeogenic gene expression. No degradation of CRTC2. Loss of SIK2-mediated phosphorylation." evidence="9">
<original>S</original>
<variation>A</variation>
<location>
<position position="171"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on COP1-mediated degradation of TORC1 under forksolin stimulation.">
<original>K</original>
<variation>R</variation>
<location>
<position position="213"/>
</location>
</feature>
<feature type="mutagenesis site" description="No interaction with COP1. Inhibition of degradation under exposure to FSK/INS." evidence="9">
<original>V</original>
<variation>A</variation>
<location>
<position position="214"/>
</location>
</feature>
<feature type="mutagenesis site" description="No interaction with COP1. Inhibition of degradation under exposure to FSK/INS." evidence="9">
<original>P</original>
<variation>A</variation>
<location>
<position position="215"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect interaction with 14-3-3 proteins." evidence="12">
<original>S</original>
<variation>A</variation>
<location>
<position position="275"/>
</location>
</feature>
<feature type="mutagenesis site" description="Translocates to the nucleus and no COP1-mediated degradation." evidence="9">
<original>K</original>
<variation>R</variation>
<location>
<position position="628"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; BAE33618." ref="1" evidence="15">
<original>S</original>
<variation>G</variation>
<location>
<position position="195"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; BAE42818." ref="1" evidence="15">
<original>G</original>
<variation>R</variation>
<location>
<position position="203"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="22"/>
<end position="44"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="48"/>
<end position="55"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5ZK1"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17242355"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21183079"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24129315"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250"/>
<evidence key="6" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q53ET0"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16148943"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16308421"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17805301"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23699513"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24570487"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28235073"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29211348"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30611118"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000305"/>
<sequence length="692" mass="73216" checksum="5BCBC416D45CFAD8" modified="2008-02-05" version="2">MATSGANGPGSATASASNPRKFSEKIALQKQRQAEETAAFEEVMMDIGSTRLQAQKLRLAYTRSSHYGGSLPNVNQIGCGLAEFQSPLHSPLDSSRSTRHHGLVERVQRDARRMVSPLRRYPRHIDSSPYSPAYLSPPPESGWRRMMPWGNLPAEKGQLFRLPSALNRTSSDSALHTSVMNPNPQDTYPGPTPPSVLPSRRGGGFLDGEMDAKVPAIEENVVDDKHLLKPWDAKKLSSSSSRPRSCEVPGINIFPSPDQPANVPVLPPAMNTGGSLPDLTNLHFPPPLPTPLDPEETVYPSLSGGNSTTNLTHTMTHLGISGGLGLGPSYDVPGLHSPLSHPSLQSSLSNPNLQASLSSPQPQLQGSHSHPSLPASSLAHHALPTTSLGHPSLSAPALSSSSSSSSTSSPVLSAPPYPASTPGASPRHRRVPLSPLSLPAGPADARRSQQQLPKQFSPTMSPTLSSITQGVPLDTSKLPTDQRLPPYPYSPPSLVIPTHPPTPKSLQQLPSQACLVQPSGGQPPGRQPHYGALYPPGSSGHGQQPYHRPINDFSLGNLEQFNMESPSTSLVLDPPAFSEGPGFLGSEGSMSGPQDPHVLNHQNLTHCSRHGSGPNIILTGDSSPGFSKEIAAALAGVPGFEVSASGLELGLGLEDELRMEPLGLEGLTMLSDPCALLPDPAVEDSFRSDRLQ</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

